Careium (CARE) Q1 2026 earnings summary

Executive summary

• Net sales rose 5.9% to SEK 219.6 million, with 10.9% growth adjusted for currency effects, reflecting growth in all markets.

• Product sales increased 18.1% and service sales grew 2.3% year-over-year.

• Operating profit (EBIT) declined to SEK 12.5 million due to investments in product development, business integration, and onboarding a major Norwegian customer.

• Profit for the period increased to SEK 8.4 million, with EPS at SEK 0.31.

• Recurring revenues and long-term contracts provide stability and a solid foundation for future growth.

Financial highlights

• Gross margin was 43.2%, down from 44.5% year-over-year.

• EBITDA was SEK 30.1 million (down 10.4%), with an EBITDA margin of 13.7%.

• Free cash flow was SEK -14.0 million, impacted by working capital normalization.

• Cash and cash equivalents stood at SEK 37.9 million at quarter-end.

• Equity ratio improved to 63.9% from 62.5% a year earlier.

Outlook and guidance

• No financial guidance provided.

• Margin pressure from ongoing investments and onboarding of a large customer in Norway expected to continue into Q2.

• Demographic trends and technology transformation in care sector support long-term growth prospects.